Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arbidol (Umifenovir) for Influenza and Common Cold
NCT01651663Phase 4Unknown
- Sponsor
- Pharmstandard
- Start
- Sep 2011
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of umifenovir in influenza, common cold, sponsored by Pharmstandard. Status: unknown.
02
Drugs
umifenovir
03
Conditions
influenzacommon cold
Beyond the preview
Go deeper on NCT01651663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01651663.